Podoplanin-positive cells are a hallmark of encapsulating peritoneal sclerosis

Nephrology Dialysis Transplantation

Volumn 26, Issue 3, 2011, Pages 1033-1041

  Braun, Niko ^a,b   Alscher, Dominik M ^a,b   Fritz, Peter ^a,b   Edenhofer, Ilka ^c,d   Kimmel, Martin ^a   Gaspert, Ariana ^c   Reimold, Fabian ^a   Bode Lesniewska, Beata ^c   Ziegler, Urs ^d   Biegger, Dagmar ^e   Wüthrich, Rudolf P ^c   Segerer, Stephan ^c,d  

^a ROBERT BOSCH HOSPITAL   (Germany)

^b Institute of Digital Medicine   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

Author keywords

encapsulating peritoneal sclerosis; EPS; peritoneal dialysis; podoplanin

Indexed keywords

PODOPLANIN; SMOOTH MUSCLE ACTIN;

ADULT; APPENDECTOMY; APPENDICITIS; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; FEMALE; HERNIOPLASTY; HUMAN; IMMUNOHISTOCHEMISTRY; LABELING INDEX; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; MESOTHELIUM CELL; MORPHOLOGY; MYOFIBROBLAST; PERITONEAL BIOPSY; PERITONEAL FIBROSIS; PRIORITY JOURNAL; STAINING;

ADULT; APPENDECTOMY; BIOPSY; CASE-CONTROL STUDIES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HERNIA; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC SYSTEM; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MYOFIBROBLASTS; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PROGNOSIS; RISK FACTORS;

EID: 79952134262     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq488     Document Type: Article

References (27)

1. Alscher DM, Reimold F. New facts about encapsulating peritoneal sclerosis as a sequel of long-term peritoneal dialysis - what can we do? Minerva Urol Nefrol 2007;59:269-279 (Pubitemid 350205657)
2. Augustine T, Brown PW, Davies SD et al. Encapsulating peritoneal sclerosis: clinical significance and implications. Nephron Clin Pract 2009;111: c149-c154, discussion c154
3. Honda K, Nitta K, Horita S et al. Histologic criteria for diagnosing encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 2003;19:169-175
4. Alscher DM, Braun N, Biegger D et al. Peritoneal mast cells in peritoneal dialysis patients, particularly in encapsulating peritoneal sclerosis patients. Am J Kidney Dis 2007;49:452-461
5. Williams JD, Craig KJ, Topley N et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002;13:470-479 (Pubitemid 34106290)
6. Williams JD, Craig KJ, von Ruhland C et al. The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int Suppl 2003; S43-S49 (Pubitemid 37452813)
7. Sherif AM, Yoshida H, Maruyama y et al. Comparison between the pathology of encapsulating sclerosis and simple sclerosis of the peritoneal membrane in chronic peritoneal dialysis. Ther Apher Dial 2008;12:33-41 (Pubitemid 351197450)
8. Raica M, Cimpean AM, Ribatti D. The role of podoplanin in tumor progression and metastasis. Anticancer Res 2008;28:2997-3006
9. Ogasawara S, Kaneko MK, Price JE et al. Characterization of antipodoplanin monoclonal antibodies: critical epitopes for neutralizing the interaction between podoplanin and CLEC-2. Hybridoma (Larchmt) 2008;27:259-267
10. Breiteneder-Geleff S, Matsui K, Soleiman A et al. Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is downregulated in puromycin nephrosis. Am J Pathol 1997;151:1141-1152 (Pubitemid 27424324)
11. Kalof AN, Cooper K. D2-40 immunohistochemistry-so far! Adv Anat Pathol 2009;16:62-64
12. Kerjaschki D, Regele HM, Moosberger I et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 2004;15:603-612 (Pubitemid 38294790)
13. Nakamoto H. Encapsulating peritoneal sclerosis-a clinician's approach to diagnosis and medical treatment. Perit Dial Int 2005;25: S30-S38 (Pubitemid 41600357)
14. Heller F, Lindenmeyer MT, Cohen CD et al. The contribution of B cells to renal interstitial inflammation. Am J Pathol 2007;170:457-468 (Pubitemid 47339383)
15. Segerer S, Banas B, Wornle M et al. CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis. Am J Pathol 2004;164:635-649 (Pubitemid 38364678)
16. Segerer S, Bohmig GA, Exner M et al. Role of CXCR3 in cellular but not humoral renal allograft rejection. Transpl Int 2005;18:676-680 (Pubitemid 41726832)
17. Ordonez NG. D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma. Hum Pathol 2005;36:372-380 (Pubitemid 40591807)
18. Garosi G, Di Paolo N, Sacchi G et al. Sclerosing peritonitis: a nosological entity. Perit Dial Int 2005;25: S110-S112 (Pubitemid 40883231)
19. Braun N, Reimold F, Biegger D et al. Fibrogenic growth factors in encapsulating peritoneal sclerosis. Nephron Clin Pract 2009;113: c88-c95
20. Honda K, Oda H. Pathology of encapsulating peritoneal sclerosis. Perit Dial Int 2005;25: S19-S29 (Pubitemid 41600356)
21. Garosi G, Di Paolo N. Inflammation and gross vascular alterations are characteristic histological features of sclerosing peritonitis. Perit Dial Int 2001;21:417-418 (Pubitemid 33014703)
22. Schwartz LB, Bradford TR, Littman BH et al. The fibrinogenolytic activity of purified tryptase from human lung mast cells. J Immunol 1985;135:2762-2767 (Pubitemid 16217148)
23. Raftery AT. Regeneration of parietal and visceral peritoneum: an electron microscopical study. J Anat 1973;115:375-392
24. Hirahara I, Ishibashi Y, Kaname S et al. Methylglyoxal induces peritoneal thickening by mesenchymal-like mesothelial cells in rats. Nephrol Dial Transplant 2009;24:437-447
25. Del Peso G, Jimenez-Heffernan JA, Bajo MA et al. Epithelial-tomesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport. Kidney Int Suppl 2008;108: S26-S33 (Pubitemid 351466514)
26. Margetts PJ, Bonniaud P, Liu L et al. Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol 2005;16:425-436 (Pubitemid 41725138)
27. Vargha R, Endemann M, Kratochwill K et al. Ex vivo reversal of in vivo transdifferentiation in mesothelial cells grown from peritoneal dialysate effluents. Nephrol Dial Transplant 2006;21:2943-2947 (Pubitemid 44542254)